ELAB

Elevai Labs (ELAB)

Elevai Labs Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ELAB

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/26	22 : 00	GlobeNewswire Inc.	Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024	NASDAQ:ELAB	Elevai Labs Inc
2024/06/14	22 : 00	GlobeNewswire Inc.	Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs	NASDAQ:ELAB	Elevai Labs Inc
2024/06/01	09 : 10	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ELAB	Elevai Labs Inc
2024/05/29	22 : 00	GlobeNewswire Inc.	Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm	NASDAQ:ELAB	Elevai Labs Inc
2024/05/25	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELAB	Elevai Labs Inc
2024/05/23	05 : 15	GlobeNewswire Inc.	Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference	NASDAQ:ELAB	Elevai Labs Inc
2024/05/16	05 : 30	GlobeNewswire Inc.	Elevai Labs Inc. Reports First Quarter 2024 Financial Results	NASDAQ:ELAB	Elevai Labs Inc
2024/05/16	05 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELAB	Elevai Labs Inc
2024/05/10	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELAB	Elevai Labs Inc
2024/05/02	21 : 30	GlobeNewswire Inc.	Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity	NASDAQ:ELAB	Elevai Labs Inc
2024/05/02	05 : 00	GlobeNewswire Inc.	Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare	NASDAQ:ELAB	Elevai Labs Inc
2024/05/01	22 : 00	GlobeNewswire Inc.	Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments	NASDAQ:ELAB	Elevai Labs Inc
2024/04/29	22 : 45	GlobeNewswire Inc.	Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments	NASDAQ:ELAB	Elevai Labs Inc
2024/04/22	21 : 00	GlobeNewswire Inc.	ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months	NASDAQ:ELAB	Elevai Labs Inc
2024/03/30	01 : 00	GlobeNewswire Inc.	Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results	NASDAQ:ELAB	Elevai Labs Inc
2024/03/18	21 : 51	InvestorsHub NewsWire	Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market	NASDAQ:ELAB	Elevai Labs Inc
2024/01/24	22 : 30	GlobeNewswire Inc.	ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office	NASDAQ:ELAB	Elevai Labs Inc
2024/01/17	23 : 07	InvestorsHub NewsWire	ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach	NASDAQ:ELAB	Elevai Labs Inc
2024/01/17	22 : 30	GlobeNewswire Inc.	ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach	NASDAQ:ELAB	Elevai Labs Inc
2024/01/17	00 : 05	InvestorsHub NewsWire	ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology	NASDAQ:ELAB	Elevai Labs Inc
2024/01/16	22 : 30	GlobeNewswire Inc.	ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology	NASDAQ:ELAB	Elevai Labs Inc
2024/01/02	23 : 15	GlobeNewswire Inc.	ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences	NASDAQ:ELAB	Elevai Labs Inc
2023/12/11	23 : 15	GlobeNewswire Inc.	Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023	NASDAQ:ELAB	Elevai Labs Inc
2023/12/07	23 : 41	GlobeNewswire Inc.	ELEVAI Labs, Inc. Expands International Distribution into Europe	NASDAQ:ELAB	Elevai Labs Inc
2023/11/29	23 : 00	GlobeNewswire Inc.	Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products	NASDAQ:ELAB	Elevai Labs Inc
2023/11/25	03 : 38	PR Newswire (US)	ELEVAI Labs, Inc. Announces Closing of $6,000,000 Initial Public Offering	NASDAQ:ELAB	Elevai Labs Inc
2023/11/25	02 : 00	GlobeNewswire Inc.	Univest Securities, LLC Announces Closing of $6 Million Initial Public Offering of Common Stock for its Client ELEVAI Labs Inc. (Nasdaq: ELAB)	NASDAQ:ELAB	Elevai Labs Inc
2005/06/24	06 : 13	Business Wire	Eon Labs Receives Final Approval for Bupropion HCl, ER 200mg Tablets and Will Begin Shipping Immediately	NASDAQ:ELAB	Elevai Labs Inc
2005/06/14	06 : 41	Business Wire	Appeals Court Affirms that Eon Labs' Itraconazole Does Not Infringe Janssen's Patent	NASDAQ:ELAB	Elevai Labs Inc
2004/02/25	04 : 34	PR Newswire (US)	Pacific Exchange to Trade Six New Options	NASDAQ:ELAB	Elevai Labs Inc